Zobrazeno 1 - 10
of 212
pro vyhledávání: '"Maher Albitar"'
Autor:
Tatyana Feldman, Maher Albitar, Hong Cheng, Kar Chow, Alessandra Petrillo, Ahmetmursel Ulusan, Andrew Ip, Alexandra Della Pia, Gabriella Magarelli, Brittany Lukasik, Lori Leslie, Pritish K. Bhattacharyya, Andrew L. Pecora, Andre H. Goy
Publikováno v:
Blood. 140:11893-11895
Autor:
Maher Albitar, Hong Zhang, Andre Goy, Zijun Y. Xu-Monette, Govind Bhagat, Carlo Visco, Alexandar Tzankov, Xiaosheng Fang, Feng Zhu, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Yong Li, Bing Xu, Ken H. Young
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 2, Pp 1-9 (2022)
Blood Cancer Journal, 12
Blood Cancer Journal, 12, 2
Albitar, M, Zhang, H, Goy, A, Xu-Monette, Z Y, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Møller, M B, Parsons, B M, van Krieken, J H, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2022, ' Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms ', Blood Cancer Journal, vol. 12, no. 2, 25 . https://doi.org/10.1038/s41408-022-00617-5
Albitar, M, Zhang, H, Goy, A H, Xu-Monette, Z, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Moller, M, Parsons, B M, Van Krieken, J H J M, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2021, ' Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms ', Blood, vol. 138, no. Suppl. 1, 2395 . https://doi.org/10.1182/blood-2021-148841
Blood Cancer Journal
Blood Cancer Journal, 12
Blood Cancer Journal, 12, 2
Albitar, M, Zhang, H, Goy, A, Xu-Monette, Z Y, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Møller, M B, Parsons, B M, van Krieken, J H, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2022, ' Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms ', Blood Cancer Journal, vol. 12, no. 2, 25 . https://doi.org/10.1038/s41408-022-00617-5
Albitar, M, Zhang, H, Goy, A H, Xu-Monette, Z, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Moller, M, Parsons, B M, Van Krieken, J H J M, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2021, ' Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms ', Blood, vol. 138, no. Suppl. 1, 2395 . https://doi.org/10.1182/blood-2021-148841
Blood Cancer Journal
Introduction: Multiple studies have demonstrated that diffuse large B-cell lymphoma (DLBCL) can be divided into subgroups based on their biology. However, these biological subgroups overlap clinically. While R-CHOP (rituximab, cyclophosphamide, doxor
Autor:
Maher Albitar, Andrew Ip, Andre H. Goy, Katherine Linder, Jeffrey Justin Estella, Ahmad Charifa, Wanlong Ma, Andrew L. Pecora, Jamie Koprivnikar, James McCloskey
Publikováno v:
Blood. 140:6270-6271
Autor:
Maher Albitar, Hong Zhang, Andrew Ip, Jeffrey Justin Estella, Ahmad Charifa, Wanlong Ma, Ipsa Sharma, Andrew L. Pecora, Lori Leslie, Tatyana Feldman, Andre H. Goy
Publikováno v:
Blood. 140:7828-7829
Autor:
Maher Albitar, Hong Zhang, Andrew L. Pecora, Andrew Ip, Andre H. Goy, Spiraggelos Antzoulatos, Wanlong Ma, Sukhdeep Kaur, Hyung C. Suh, Michele L. Donato, Scott D. Rowley
Publikováno v:
Blood. 140:4757-4758
Autor:
Feng Zhu, Qingyan Au, Zijun Y. Xu-Monette, Ken H. Young, Jooryung Huh, Li Wei, Bing Xu, Youli Zu, Jane N. Winter, C. Visco, Xiaosheng Fang, Eric D. Hsi, Fredrick B. Hagemeister, J. Han van Krieken, Mate Nagy, A. Tzankov, Miguel A. Piris, Michael Boe Møller, Hua You, April Chiu, Karen Dybkaer, Wayne Tam, Andrés José María Ferreri, Benjamin M. Parsons, Harry Nunns, Yong Li, Govind Bhagat, Maher Albitar, Maurilio Ponzoni
Publikováno v:
Oncoimmunology, 10, 1
You, H, Xu-Monette, Z Y, Wei, L, Nunns, H, Nagy, M L, Bhagat, G, Fang, X, Zhu, F, Visco, C, Tzankov, A, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Møller, M B, Parsons, B M, Van Krieken, J H, Piris, M A, Winter, J N, Li, Y, Au, Q, Xu, B, Albitar, M & Young, K H 2021, ' Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma ', OncoImmunology, vol. 10, no. 1, 1928365 . https://doi.org/10.1080/2162402X.2021.1928365
Oncoimmunology, 10
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
You, H, Xu-Monette, Z Y, Wei, L, Nunns, H, Nagy, M L, Bhagat, G, Fang, X, Zhu, F, Visco, C, Tzankov, A, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Møller, M B, Parsons, B M, Van Krieken, J H, Piris, M A, Winter, J N, Li, Y, Au, Q, Xu, B, Albitar, M & Young, K H 2021, ' Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma ', OncoImmunology, vol. 10, no. 1, 1928365 . https://doi.org/10.1080/2162402X.2021.1928365
Oncoimmunology, 10
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma with high mutation burdens but a low response rate to immune checkpoint inhibitors. In this study, we performed targeted next-generation sequencing and fluorescent multiplex im
Autor:
Andre Goy, Hong Zhang, Andrew Ip, Ivan De Dios, Jeffrey Estella, Tatyana Feldman, Andrew L. Pecora, Maher Albitar, Wanlong Ma, Lori A. Leslie
Publikováno v:
Blood. 138:4480-4480
Introduction: Liquid biopsy has been reported to be useful in predicting residual disease in patients with diffuse large B-cell lymphoma (DLBCL). Most of the studies focused on quantifying the level of circulating lymphoma-specific DNA. We explored t
Autor:
Andrew Ip, Andre Goy, Scott D. Rowley, Hong Zhang, Andrew L. Pecora, Ivan De Dios, Hyung C. Suh, Sukhdeep Kaur, Michele L. Donato, Wanlong Ma, Maher Albitar, Spiraggelos Antzoulatos
Publikováno v:
Blood. 138:2892-2892
Introduction: Acute graft-vs.-host disease (aGVHD) remains a major diagnostic and clinical problem in patients after allogenic hematopoietic stem cell transplant (HSCT). Finding biomarkers that play a role in aGVHD not only helps in predicting and di
Autor:
Andrew Ip, Ivan De Dios, Sukhdeep Kaur, Hyung C. Suh, Andre Goy, Scott D. Rowley, Jeffrey Estella, Andrew L. Pecora, Maher Albitar, Michele L. Donato, Hong Zhang, Wanlong Ma
Publikováno v:
Blood. 138:1828-1828
Introduction: Using next generation sequencing (NGS) in monitoring residual disease in patients with myeloid neoplasms is complicated by the significant heterogeneity in these diseases and the frequent presence of CHIP (clonal hematopoiesis of indete
Autor:
Andre Goy, Jeffrey Estella, James K. McCloskey, Andrew Ip, Jamie Koprivnikar, Andrew L. Pecora, Ivan De Dios, Wanlong Ma, Maher Albitar
Publikováno v:
Blood. 138:3463-3463
Introduction: Cytogenetic analysis is important for stratifying patients with various myeloid neoplasms. It has been reported that whole-genome sequencing can be used as an alternative to cytogenetic analysis in acute myeloid leukemia (AML) and myelo